You are here

Home

Clinical Trials: Heart Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Monday, March 1, 2021 - 12:00
Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease. (ACESO-IHD)
Conditions:   Diabetes Mellitus;   Ischemic Heart Disease
Interventions:   Drug: 100 million Allogeneic Mesenchymal Human Stem Cells;   Other: Placebo
Sponsors:   Joshua M Hare;   National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting
Posted: Thursday, January 28, 2021 - 12:00
Heart Patch for Myocardial Infarction COVID-19
Conditions:   Myocardial Infarction;   Heart Diseases
Intervention:   Device: Heart patch seeded with autologous cardiomyocytes and amnion epithelial stem cells
Sponsor:   Rumah Sakit Pusat Angkatan Darat Gatot Soebroto
Not yet recruiting
Posted: Tuesday, January 5, 2021 - 12:00
ADR-002K for Patients With Ischemic Cardiomyopathy Who Undergo Coronary Artery Bypass Surgery
Condition:   D017202
Intervention:   Biological: ADR-002K administration
Sponsors:   Osaka University;   Rohto Pharmaceutical Co., Ltd.
Recruiting
Posted: Friday, October 9, 2020 - 12:00
Mutation-specific Therapy for the Long QT Syndrome
Condition:   Long QT Syndrome
Intervention:   Drug: Lumacaftor / Ivacaftor, Orkambi® Oral Tablet
Sponsor:   Istituto Auxologico Italiano
Not yet recruiting
Posted: Wednesday, September 16, 2020 - 12:00
WJMSCs Anti-inflammatory Therapy in Acute Myocardial Infarction
Condition:   Acute Myocardial Infarction
Interventions:   Biological: Intravenous infusion placebo;   Biological: Intravenous infusion WJMSCs
Sponsors:   Navy General Hospital, Beijing;   Peking University Third Hospital;   Peking Union Medical College Hospital;   Xijing Hospital;   Chinese PLA General Hospital
Not yet recruiting
Posted: Wednesday, September 16, 2020 - 12:00
WJMSCs Anti-inflammatory Therapy in Coronary Artery Disease
Condition:   Coronary Artery Disease
Intervention:   Biological: Intravenous infusion human umbilical Wharton's jelly-derived mesenchymal stem Cell or placebo PBS
Sponsors:   Navy General Hospital, Beijing;   Chinese PLA General Hospital;   Peking University Third Hospital;   Peking Union Medical College Hospital;   Xijing Hospital
Not yet recruiting
Posted: Monday, July 20, 2020 - 12:00
Transendocardial Injection of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy
Condition:   Non-ischemic Dilated Cardiomyopathy
Interventions:   Biological: allogeneic human mesenchymal stem cells (hMSCs);   Other: Placebo
Sponsors:   Joshua M Hare;   United States Department of Defense;   The University of Texas Health Science Center, Houston
Not yet recruiting
Posted: Friday, May 22, 2020 - 12:00
Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biological Ventricular Assist Tissue in Terminal Heart Failure
Condition:   Heart Failure
Intervention:   Biological: EHM implantation
Sponsors:   University Medical Center Goettingen;   Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK);   University Medical Center Freiburg
Not yet recruiting
Posted: Friday, April 10, 2020 - 12:00
ASC Therapy for Patients With Severe Respiratory COVID-19
Condition:   Respiratory Tract Diseases
Intervention:   Drug: Stem Cell Product
Sponsor:   Rigshospitalet, Denmark
Not yet recruiting
Posted: Thursday, April 9, 2020 - 12:00
Stem Cell in Acute Myocardial Infarction
Condition:   Acute Myocardial Infarction
Intervention:   Biological: Mesenchymal Stem Cells
Sponsor:   PT. Prodia Stem Cell Indonesia
Recruiting

Pages